Tech Mahindra: Q4FY25 Result Review
IDBI Capital
Summary | Date | Stock | Author | LTP | Target | Price at reco (Change since reco%) |
Upside(%) | Type | Report | Discuss | |
---|---|---|---|---|---|---|---|---|---|---|---|
25 Apr 2025 | Tech Mahindra |
IDBI Capital
|
1576.00 | 1678.00 | 1462.00 (7.80%) | 6.47 |
Buy
|
||||
25 Apr 2025 | Aavas Financiers |
IDBI Capital
|
1802.20 | 2340.00 | 2038.10 (-11.57%) | 29.84 |
Hold
|
||||
25 Apr 2025 | Aavas Financiers |
ICICI Securities Limited
|
1802.20 | 2100.00 | 2038.10 (-11.57%) | Target met |
Hold
|
Steady quarter; NIM pressure visible in H1FY26
ICICI Securities Limited
Aavas Financiers (Aavas) reported in-line Q4FY25 financial performance, evident in strong 6% QoQ AUM growth, steady 15bps credit cost, 46bps QoQ dip in 1+ DPD to 3.39% and RoA at 3.3%.
|
|||
25 Apr 2025 | Cyient |
ICICI Securities Limited
|
1290.20 | 1190.00 | 1170.80 (10.20%) | Target met |
Hold
|
A rocky road to recovery
ICICI Securities Limited
Cyient-DET reported a miss on revenue growth and margin in Q4, exiting FY25 with a full-year 3% YoY CC decline, steeper than its (-2.7%) guidance. Transportation vertical’s decline was cushioned by some traction in the aerospace sub-vertical and sustainability.
|
|||
25 Apr 2025 | L&T Technology |
ICICI Securities Limited
|
4470.50 | 3870.00 | 4256.10 (5.04%) | 13.43 |
Sell
|
Muted quarter; optimistic outlook on deal win traction
ICICI Securities Limited
LTTS reported a slight underperformance on the revenue growth front, caused by the prevailing macro uncertainties. The company missed its 10% YoY guided revenue growth target mildly for FY25. Operating margin, at 13.2%, was down 270bps on account of Intelliswift consolidation impact.
|
|||
25 Apr 2025 | Axis Bank |
ICICI Securities Limited
|
1195.80 | 1400.00 | 1166.30 (2.53%) | 17.08 |
Buy
|
Sustains prioritising NIM over growth; asset quality improves QoQ
ICICI Securities Limited
Axis Bank (Axis) reported ~13% rise in Q4FY25 net profit to INR 71.2bn (flattish YoY; 8% beat) on the back of ~2% rise in PPOP (in-line). Provisions declined sharply, led by INR 8bn reversals on government-backed SR.
|
|||
25 Apr 2025 | SBI Life Insurance |
Emkay
|
1757.80 | 1950.00 | 1695.10 (3.70%) | 10.93 |
Buy
|
||||
25 Apr 2025 | SBI Life Insurance |
Axis Direct
|
1757.80 | 1900.00 | 1695.10 (3.70%) | 8.09 |
Buy
|
||||
25 Apr 2025 | ACC |
Axis Direct
|
1920.20 | 2420.00 | 1938.00 (-0.92%) | 26.03 |
Buy
|
||||
25 Apr 2025 | Dalmia Bharat |
Axis Direct
|
2057.20 | 2260.00 | 1965.90 (4.64%) | 9.86 |
Buy
|
||||
more
loading
|